Mitochondrial complex II, a novel target for anti-cancer agents

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1827, Issue 5, 2013, Pages 552-564

  Kluckova, Katarina ^a   Bezawork Geleta, Ayanachew ^b   Rohlena, Jakub ^a   Dong, Lanfeng ^c   Neuzil, Jiri ^a,c  

^a INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^b LA TROBE UNIVERSITY   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Anti cancer agent; Cancer therapy; Complex II; Mitocan; Mitochondrion

Indexed keywords

3 NITROPROPIONIC ACID; ALPHA TOCOPHEROL SUCCINATE; ANTINEOPLASTIC AGENT; ATPENIN B; BROMOPYRUVIC ACID; MALONIC ACID; PYRUVIC ACID DERIVATIVE; SUCCINATE DEHYDROGENASE (UBIQUINONE); THENOYLTRIFLUOROACETONE; TROGLITAZONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER SUSCEPTIBILITY; ELECTRON TRANSPORT; GLYCOLYSIS; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX II; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 84875740213     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2012.10.015     Document Type: Review

References (155)

1. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
2. S. Jones, X. Zhang, D.W. Parsons, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, S.M. Hong, B. Fu, M.T. Lin, E.S. Calhoun, M. Kamiyama, K. Walter, T. Nikolskaya, Y. Nikolsky, J. Hartigan, D.R. Smith, M. Hidalgo, S.D. Leach, A.P. Klein, E.M. Jaffee, M. Goggins, A. Maitra, C. Iacobuzio-Donahue, J.R. Eshleman, S.E. Kern, R.H. Hruban, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, and K.W. Kinzler Core signaling pathways in human pancreatic cancers revealed by global genomic analyses Science 321 2008 1801 1806
3. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, A. Olivi, R. McLendon, B.A. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D.A. Busam, H. Tekleab, L.A. Diaz Jr., J. Hartigan, D.R. Smith, R.L. Strausberg, S.K. Marie, S.M. Shinjo, H. Yan, G.J. Riggins, D.D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V.E. Velculescu, and K.W. Kinzler An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
4. E. Check Hayden Cancer complexity slows quest for cure Nature 455 2008 148
5. M. Gerlinger, A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, I. Varela, B. Phillimore, S. Begum, N.Q. McDonald, A. Butler, D. Jones, K. Raine, C. Latimer, C.R. Santos, M. Nohadani, A.C. Eklund, B. Spencer-Dene, G. Clark, L. Pickering, G. Stamp, M. Gore, Z. Szallasi, J. Downward, P.A. Futreal, and C. Swanton Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2012 883 892
6. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
7. R. Siegel, C. DeSantis, K. Virgo, K. Stein, A. Mariotto, T. Smith, D. Cooper, T. Gansler, C. Lerro, S. Fedewa, C. Lin, C. Leach, R.S. Cannady, H. Cho, S. Scoppa, M. Hachey, R. Kirch, A. Jemal, and E. Ward Cancer treatment and survivorship statistics, 2012 CA Cancer J. Clin. 62 2012 220 241
8. E.P. Simard, E.M. Ward, R. Siegel, A. Jemal, Cancers with increasing incidence trends in the United States: 1999 through 2008, CA Cancer J. Clin. (in press).
9. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629 (Pubitemid 39006738)
10. S.J. Ralph, S. Rodriguez-Enriquez, J. Neuzil, E. Saavedra, and R. Moreno-Sanchez The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy Mol. Aspects Med. 31 2010 145 170
11. V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 18 2008 165 173
12. S. Fulda, L. Galluzzi, and G. Kroemer Targeting mitochondria for cancer therapy Nat. Rev. Drug Discov. 9 2010 447 464
13. D.C. Wallace, W. Fan, and V. Procaccio Mitochondrial energetics and therapeutics Annu. Rev. Pathol. 5 2010 297 348
14. F. Wang, M.A. Ogasawara, and P. Huang Small mitochondria-targeting molecules as anti-cancer agents Mol. Aspects Med. 31 2010 75 92
15. S. Fulda, and G. Kroemer Mitochondria as therapeutic targets for the treatment of malignant disease Antioxid. Redox Signal. 15 2011 2937 2949
16. O. Kepp, L. Galluzzi, M. Lipinski, J. Yuan, and G. Kroemer Cell death assays for drug discovery Nat. Rev. Drug Discov. 10 2011 221 237
17. J. Neuzil, X.F. Wang, L.F. Dong, P. Low, and S.J. Ralph Molecular mechanism of 'mitocan'-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins FEBS Lett. 580 2006 5125 5129 (Pubitemid 44415781)
18. J. Neuzil, J.C. Dyason, R. Freeman, L.F. Dong, L. Prochazka, X.F. Wang, I. Scheffler, and S.J. Ralph Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II J. Bioenerg. Biomembr. 39 2007 65 72 (Pubitemid 46877173)
19. J. Neuzil, L.F. Dong, J. Rohlena, J. Truksa, S.J. Ralph, Classification of mitocans, anti-cancer drugs acting on mitochondria, Mitochondrion (in press).
20. J. Rohlena, L.F. Dong, S.J. Ralph, and J. Neuzil Anticancer drugs targeting the mitochondrial electron transport chain Antioxid. Redox Signal. 15 2011 2951 2974
21. J. Neuzil, T. Weber, A. Schroder, M. Lu, G. Ostermann, N. Gellert, G.C. Mayne, B. Olejnicka, A. Negre-Salvayre, M. Sticha, R.J. Coffey, and C. Weber Induction of cancer cell apoptosis by α-tocopheryl succinate: molecular pathways and structural requirements FASEB J. 15 2001 403 415 (Pubitemid 32141432)
22. T. Weber, M. Lu, L. Andera, H. Lahm, N. Gellert, M.W. Fariss, V. Korinek, W. Sattler, D.S. Ucker, A. Terman, A. Schroder, W. Erl, U.T. Brunk, R.J. Coffey, C. Weber, and J. Neuzil Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo Clin. Cancer Res. 8 2002 863 869 (Pubitemid 34742119)
23. T. Weber, H. Dalen, L. Andera, A. Negre-Salvayre, N. Auge, M. Sticha, A. Lloret, A. Terman, P.K. Witting, M. Higuchi, M. Plasilova, J. Zivny, N. Gellert, C. Weber, and J. Neuzil Mitochondria play a central role in apoptosis induced by α-tocopheryl succinate, an agent with antineoplastic activity: comparison with receptor-mediated pro-apoptotic signaling Biochemistry 42 2003 4277 4291 (Pubitemid 36418320)
24. M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P.K. Witting, A. Procopio, and J. Neuzil α-Tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress J. Biol. Chem. 280 2005 25369 25376 (Pubitemid 40962239)
25. K. Valis, L. Prochazka, E. Boura, J. Chladova, T. Obsil, J. Rohlena, J. Truksa, L.F. Dong, S.J. Ralph, and J. Neuzil Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner Cancer Res. 71 2011 946 954
26. L.F. Dong, P. Low, J.C. Dyason, X.F. Wang, L. Prochazka, P.K. Witting, R. Freeman, E. Swettenham, K. Valis, J. Liu, R. Zobalova, J. Turanek, D.R. Spitz, F.E. Domann, I.E. Scheffler, S.J. Ralph, and J. Neuzil α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II Oncogene 27 2008 4324 4335 (Pubitemid 352010000)
27. L.F. Dong, R. Freeman, J. Liu, R. Zobalova, A. Marin-Hernandez, M. Stantic, J. Rohlena, K. Valis, S. Rodriguez-Enriquez, B. Butcher, J. Goodwin, U.T. Brunk, P.K. Witting, R. Moreno-Sanchez, I.E. Scheffler, S.J. Ralph, and J. Neuzil Suppression of tumor growth in vivo by the mitocan α-tocopheryl succinate requires respiratory complex II Clin. Cancer Res. 15 2009 1593 1600
28. B.A. Ackrell Progress in understanding structure-function relationships in respiratory chain complex II FEBS Lett. 466 2000 1 5 (Pubitemid 30050672)
29. M. Saraste Oxidative phosphorylation at the fin de siecle Science 283 1999 1488 1493 (Pubitemid 29133351)
30. G. Cecchini Function and structure of complex II of the respiratory chain Annu. Rev. Biochem. 72 2003 77 109 (Pubitemid 36930442)
31. V. Yankovskaya, R. Horsefield, S. Tornroth, C. Luna-Chavez, H. Miyoshi, C. Leger, B. Byrne, G. Cecchini, and S. Iwata Architecture of succinate dehydrogenase and reactive oxygen species generation Science 299 2003 700 704 (Pubitemid 36159483)
32. E. Maklashina, D.A. Berthold, and G. Cecchini Anaerobic expression of Escherichia coli succinate dehydrogenase: functional replacement of fumarate reductase in the respiratory chain during anaerobic growth J. Bacteriol. 180 1998 5989 5996 (Pubitemid 28514218)
33. C. Hagerhall Succinate: quinone oxidoreductases. Variations on a conserved theme Biochim. Biophys. Acta 1320 1997 107 141 (Pubitemid 27248508)
34. F. Sun, X. Huo, Y. Zhai, A. Wang, J. Xu, D. Su, M. Bartlam, and Z. Rao Crystal structure of mitochondrial respiratory membrane protein complex II Cell 121 2005 1043 1057 (Pubitemid 40884395)
35. M. McKenzie, and M.T. Ryan Assembly factors of human mitochondrial complex I and their defects in disease IUBMB Life 62 2010 497 502
36. H.X. Hao, O. Khalimonchuk, M. Schraders, N. Dephoure, J.P. Bayley, H. Kunst, P. Devilee, C.W. Cremers, J.D. Schiffman, B.G. Bentz, S.P. Gygi, D.R. Winge, H. Kremer, and J. Rutter SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma Science 325 2009 1139 1142
37. K. Nakamura, M. Yamaki, M. Sarada, S. Nakayama, C.R. Vibat, R.B. Gennis, T. Nakayashiki, H. Inokuchi, S. Kojima, and K. Kita Two hydrophobic subunits are essential for the heme b ligation and functional assembly of complex II (succinate-ubiquinone oxidoreductase) from Escherichia coli J. Biol. Chem. 271 1996 521 527 (Pubitemid 26026621)
38. J. Nouws, L.G. Nijtmans, J.A. Smeitink, and R.O. Vogel Assembly factors as a new class of disease genes for mitochondrial complex I deficiency: cause, pathology and treatment options Brain 135 2012 12 22
39. D. Ghezzi, P. Goffrini, G. Uziel, R. Horvath, T. Klopstock, H. Lochmuller, P. D'Adamo, P. Gasparini, T.M. Strom, H. Prokisch, F. Invernizzi, I. Ferrero, and M. Zeviani SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy Nat. Genet. 41 2009 654 656
40. A. Atkinson, O. Khalimonchuk, P. Smith, H. Sabic, D. Eide, and D.R. Winge Mzm1 influences a labile pool of mitochondrial zinc important for respiratory function J. Biol. Chem. 285 2010 19450 19459
41. H.X. Hao, and J. Rutter Revealing human disease genes through analysis of the yeast mitochondrial proteome Cell Cycle 8 2009 4007 4008
42. M.B. McNeil, J.S. Clulow, N.M. Wilf, G.P. Salmond, and P.C. Fineran SdhE is a conserved protein required for flavinylation of succinate dehydrogenase in bacteria J. Biol. Chem. 287 2012 18418 18428
43. T.A. Giancaspero, R. Wait, E. Boles, and M. Barile Succinate dehydrogenase flavoprotein subunit expression in Saccharomyces cerevisiae-involvement of the mitochondrial FAD transporter, Flx1p FEBS J. 275 2008 1103 1117 (Pubitemid 351342207)
44. E. Dibrov, S. Fu, and B.D. Lemire The Saccharomyces cerevisiae TCM62 gene encodes a chaperone necessary for the assembly of the mitochondrial succinate dehydrogenase (complex II) J. Biol. Chem. 273 1998 32042 32048 (Pubitemid 29177146)
45. J. Rutter, D.R. Winge, and J.D. Schiffman Succinate dehydrogenase - assembly, regulation and role in human disease Mitochondrion 10 2010 393 401
46. A. Tzagoloff, J. Jang, D.M. Glerum, and M. Wu FLX1 codes for a carrier protein involved in maintaining a proper balance of flavin nucleotides in yeast mitochondria J. Biol. Chem. 271 1996 7392 7397 (Pubitemid 26107007)
47. C. Klanner, W. Neupert, and T. Langer The chaperonin-related protein Tcm62p ensures mitochondrial gene expression under heat stress FEBS Lett. 470 2000 365 369 (Pubitemid 30169294)
48. L.W. Finley, W. Haas, V. Desquiret-Dumas, D.C. Wallace, V. Procaccio, S.P. Gygi, and M.C. Haigis Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity PLoS One 6 2011 e23295
49. H. Cimen, M.J. Han, Y. Yang, Q. Tong, H. Koc, and E.C. Koc Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria Biochemistry 49 2010 304 311
50. M. Salvi, N.A. Morrice, A.M. Brunati, and A. Toninello Identification of the flavoprotein of succinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinase FEBS Lett. 581 2007 5579 5585 (Pubitemid 350179765)
51. B.E. Baysal, R.E. Ferrell, J.E. Willett-Brozick, E.C. Lawrence, D. Myssiorek, A. Bosch, A. van der Mey, P.E. Taschner, W.S. Rubinstein, E.N. Myers, C.W. Richard III, C.J. Cornelisse, P. Devilee, and B. Devlin Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma Science 287 2000 848 851 (Pubitemid 30084326)
52. S. Niemann, and U. Muller Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Nat. Genet. 26 2000 268 270
53. D. Astuti, F. Douglas, T.W. Lennard, I.A. Aligianis, E.R. Woodward, D.G. Evans, C. Eng, F. Latif, and E.R. Maher Germline SDHD mutation in familial phaeochromocytoma Lancet 357 2001 1181 1182 (Pubitemid 32378695)
54. D. Astuti, F. Latif, A. Dallol, P.L. Dahia, F. Douglas, E. George, F. Skoldberg, E.S. Husebye, C. Eng, and E.R. Maher Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am. J. Hum. Genet. 69 2001 49 54 (Pubitemid 32614017)
55. N. Burnichon, J.J. Briere, R. Libe, L. Vescovo, J. Riviere, F. Tissier, E. Jouanno, X. Jeunemaitre, P. Benit, A. Tzagoloff, P. Rustin, J. Bertherat, J. Favier, and A.P. Gimenez-Roqueplo SDHA is a tumor suppressor gene causing paraganglioma Hum. Mol. Genet. 19 2010 3011 3020
56. L. Fishbein, and K.L. Nathanson Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background Cancer Genet. 205 2012 1 11
57. C. Bardella, P.J. Pollard, and I. Tomlinson SDH mutations in cancer Biochim. Biophys. Acta 1807 2011 1432 1443
58. K.A. Janeway, S.Y. Kim, M. Lodish, V. Nose, P. Rustin, J. Gaal, P.L. Dahia, B. Liegl, E.R. Ball, M. Raygada, A.H. Lai, L. Kelly, J.L. Hornick, M. O'Sullivan, R.R. de Krijger, W.N. Dinjens, G.D. Demetri, C.R. Antonescu, J.A. Fletcher, L. Helman, and C.A. Stratakis Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations Proc. Natl. Acad. Sci. U. S. A. 108 2011 314 318
59. P.J. Pollard, J.J. Briere, N.A. Alam, J. Barwell, E. Barclay, N.C. Wortham, T. Hunt, M. Mitchell, S. Olpin, S.J. Moat, I.P. Hargreaves, S.J. Heales, Y.L. Chung, J.R. Griffiths, A. Dalgleish, J.A. McGrath, M.J. Gleeson, S.V. Hodgson, R. Poulsom, P. Rustin, and I.P. Tomlinson Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations Hum. Mol. Genet. 14 2005 2231 2239 (Pubitemid 41418022)
60. J. Favier, J.J. Briere, N. Burnichon, J. Riviere, L. Vescovo, P. Benit, I. Giscos-Douriez, A. De Reynies, J. Bertherat, C. Badoual, F. Tissier, L. Amar, R. Libe, P.F. Plouin, X. Jeunemaitre, P. Rustin, and A.P. Gimenez-Roqueplo The Warburg effect is genetically determined in inherited pheochromocytomas PLoS One 4 2009 e7094
61. S.M. Fliedner, N. Kaludercic, X.S. Jiang, H. Hansikova, Z. Hajkova, J. Sladkova, A. Limpuangthip, P.S. Backlund, R. Wesley, L. Martiniova, I. Jochmanova, N.K. Lendvai, J. Breza, A.L. Yergey, N. Paolocci, A.S. Tischler, J. Zeman, F.D. Porter, H. Lehnert, and K. Pacak Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue PLoS One 7 2012 e40949
62. M.A. Selak, S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, and E. Gottlieb Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase Cancer Cell 7 2005 77 85 (Pubitemid 40126384)
63. Y. Ni, X. He, J. Chen, J. Moline, J. Mester, M.S. Orloff, M.D. Ringel, and C. Eng Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53 Hum. Mol. Genet. 21 2012 300 310
64. E.H. Smith, R. Janknecht, and L.J. Maher III Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma Hum. Mol. Genet. 16 2007 3136 3148 (Pubitemid 350131331)
65. C. Lu, P.S. Ward, G.S. Kapoor, D. Rohle, S. Turcan, O. Abdel-Wahab, C.R. Edwards, R. Khanin, M.E. Figueroa, A. Melnick, K.E. Wellen, D.M. O'Rourke, S.L. Berger, T.A. Chan, R.L. Levine, I.K. Mellinghoff, and C.B. Thompson IDH mutation impairs histone demethylation and results in a block to cell differentiation Nature 483 2012 474 478
66. M. Xiao, H. Yang, W. Xu, S. Ma, H. Lin, H. Zhu, L. Liu, Y. Liu, C. Yang, Y. Xu, S. Zhao, D. Ye, Y. Xiong, and K.L. Guan Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors Genes Dev. 26 2012 1326 1338
67. C.L. Quinlan, A.L. Orr, I.V. Perevoshchikova, J.R. Treberg, B.A. Ackrell, and M.D. Brand Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions J. Biol. Chem. 287 2012 27255 27264
68. C. Gleason, S. Huang, L.F. Thatcher, R.C. Foley, C.R. Anderson, A.J. Carroll, A.H. Millar, and K.B. Singh Mitochondrial complex II has a key role in mitochondrial-derived reactive oxygen species influence on plant stress gene regulation and defense Proc. Natl. Acad. Sci. U. S. A. 108 2011 10768 10773
69. R.D. Guzy, B. Sharma, E. Bell, N.S. Chandel, and P.T. Schumacker Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis Mol. Cell. Biol. 28 2008 718 731
70. 2 Free Radic. Biol. Med. 52 2012 160 166
71. T. Ishii, K. Yasuda, A. Akatsuka, O. Hino, P.S. Hartman, and N. Ishii A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis Cancer Res. 65 2005 203 209 (Pubitemid 40070811)
72. A.M. Cervera, N. Apostolova, F.L. Crespo, M. Mata, and K.J. McCreath Cells silenced for SDHB expression display characteristic features of the tumor phenotype Cancer Res. 68 2008 4058 4067
73. M.A. Selak, R.V. Duran, and E. Gottlieb Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells Biochim. Biophys. Acta 1757 2006 567 572 (Pubitemid 43993873)
74. V. Kantorovich, and K. Pacak Pheochromocytoma and paraganglioma Prog. Brain Res. 182 2010 343 373
75. B. Pasini, and C.A. Stratakis SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes J. Intern. Med. 266 2009 19 42
76. F.H. van Nederveen, J. Gaal, J. Favier, E. Korpershoek, R.A. Oldenburg, E.M. de Bruyn, H.F. Sleddens, P. Derkx, J. Riviere, H. Dannenberg, B.J. Petri, P. Komminoth, K. Pacak, W.C. Hop, P.J. Pollard, M. Mannelli, J.P. Bayley, A. Perren, S. Niemann, A.A. Verhofstad, A.P. de Bruine, E.R. Maher, F. Tissier, T. Meatchi, C. Badoual, J. Bertherat, L. Amar, D. Alataki, E. Van Marck, F. Ferrau, J. Francois, W.W. de Herder, M.P. Peeters, A. van Linge, J.W. Lenders, A.P. Gimenez-Roqueplo, R.R. de Krijger, and W.N. Dinjens An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis Lancet Oncol. 10 2009 764 771
77. E.D. MacKenzie, M.A. Selak, D.A. Tennant, L.J. Payne, S. Crosby, C.M. Frederiksen, D.G. Watson, and E. Gottlieb Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells Mol. Cell. Biol. 27 2007 3282 3289 (Pubitemid 46685207)
78. D.A. Tennant, C. Frezza, E.D. MacKenzie, Q.D. Nguyen, L. Zheng, M.A. Selak, D.L. Roberts, C. Dive, D.G. Watson, E.O. Aboagye, and E. Gottlieb Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death Oncogene 28 2009 4009 4021
79. Y. Ni, and C. Eng Vitamin E protects against lipid peroxidation and rescues tumorigenic phenotypes in Cowden/Cowden-like patient-derived lymphoblast cells with germline SDHx variants Clin. Cancer Res. 18 2012 4954 4961
80. L.F. Dong, V.J. Jameson, D. Tilly, J. Cerny, E. Mahdavian, A. Marin-Hernandez, L. Hernandez-Esquivel, S. Rodriguez-Enriquez, J. Stursa, P.K. Witting, B. Stantic, J. Rohlena, J. Truksa, K. Kluckova, J.C. Dyason, M. Ledvina, B.A. Salvatore, R. Moreno-Sanchez, M.J. Coster, S.J. Ralph, R.A. Smith, and J. Neuzil Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II J. Biol. Chem. 286 2011 3717 3728
81. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
82. X.L. Zu, and M. Guppy Cancer metabolism: facts, fantasy, and fiction Biochem. Biophys. Res. Commun. 313 2004 459 465 (Pubitemid 38021849)
83. R. Moreno-Sanchez, S. Rodriguez-Enriquez, A. Marin-Hernandez, and E. Saavedra Energy metabolism in tumor cells FEBS J. 274 2007 1393 1418 (Pubitemid 46333738)
84. M. Busk, M.R. Horsman, P.E. Kristjansen, A.J. van der Kogel, J. Bussink, and J. Overgaard Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia Int. J. Cancer 122 2008 2726 2734 (Pubitemid 351631374)
85. F. Pistollato, S. Abbadi, E. Rampazzo, G. Viola, A. Della Puppa, L. Cavallini, C. Frasson, L. Persano, D.M. Panchision, and G. Basso Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma Biochem. Pharmacol. 80 2010 1517 1527
86. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth Cancer Cell 11 2007 37 51 (Pubitemid 46054520)
87. A. Le, C.R. Cooper, A.M. Gouw, R. Dinavahi, A. Maitra, L.M. Deck, R.E. Royer, D.L. Vander Jagt, G.L. Semenza, and C.V. Dang Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression Proc. Natl. Acad. Sci. U. S. A. 107 2010 2037 2042
88. I.E. Scheffler Mitochondria Second edition 2008 John Wiley & Sons, Inc. Hoboken, New Jersey, USA
89. T. Albayrak, V. Scherhammer, N. Schoenfeld, E. Braziulis, T. Mund, M.K. Bauer, I.E. Scheffler, and S. Grimm The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction Mol. Biol. Cell 14 2003 3082 3096 (Pubitemid 37013112)
90. J. Neuzil, T. Weber, A. Terman, C. Weber, and U.T. Brunk Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic role Redox Rep. 6 2001 143 151 (Pubitemid 32694476)
91. J. Neuzil, T. Weber, N. Gellert, and C. Weber Selective cancer cell killing by α-tocopheryl succinate Br. J. Cancer 84 2001 87 89 (Pubitemid 32102509)
92. X.F. Wang, M. Birringer, L.F. Dong, P. Veprek, P. Low, E. Swettenham, M. Stantic, L.H. Yuan, R. Zobalova, K. Wu, M. Ledvina, S.J. Ralph, and J. Neuzil A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression Cancer Res. 67 2007 3337 3344 (Pubitemid 46724873)
93. K. Kline, W. Yu, and B.G. Sanders Vitamin E and breast cancer J. Nutr. 134 2004 3458S 3462S (Pubitemid 39587590)
94. M.P. Malafa, F.D. Fokum, J. Andoh, L.T. Neitzel, S. Bandyopadhyay, R. Zhan, M. Iiizumi, E. Furuta, E. Horvath, and K. Watabe Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis Int. J. Cancer 118 2006 2441 2447
95. J. Quin, D. Engle, A. Litwiller, E. Peralta, A. Grasch, T. Boley, and S. Hazelrigg Vitamin E succinate decreases lung cancer tumor growth in mice J. Surg. Res. 127 2005 139 143 (Pubitemid 41080625)
96. M. Tomasetti, N. Gellert, A. Procopio, and J. Neuzil A vitamin E analogue suppresses malignant mesothelioma in a preclinical model: a future drug against a fatal neoplastic disease? Int. J. Cancer 109 2004 641 642 (Pubitemid 38405608)
97. M.P. Malafa, F.D. Fokum, A. Mowlavi, M. Abusief, and M. King Vitamin E inhibits melanoma growth in mice Surgery 131 2002 85 91 (Pubitemid 34118601)
98. K. Anderson, M. Simmons-Menchaca, K.A. Lawson, J. Atkinson, B.G. Sanders, and K. Kline Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E succinate and vitamin E analogue, α-TEA Cancer Res. 64 2004 4263 4269 (Pubitemid 38802432)
99. T. Hahn, L. Szabo, M. Gold, L. Ramanathapuram, L.H. Hurley, and E.T. Akporiaye Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer Cancer Res. 66 2006 9374 9378 (Pubitemid 44623632)
100. L.F. Dong, G. Grant, H. Massa, R. Zobalova, E. Akporiaye, and J. Neuzil α-Tocopheryloxyacetic acid is superior to alpha-tocopheryl succinate in suppressing HER2-high breast carcinomas due to its higher stability Int. J. Cancer 131 2012 1052 1058
101. W. Yu, B.G. Sanders, and K. Kline RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria Cancer Res. 63 2003 2483 2491 (Pubitemid 36605187)
102. L. Prochazka, L.F. Dong, K. Valis, R. Freeman, S.J. Ralph, J. Turanek, and J. Neuzil α-Tocopheryl succinate causes mitochondrial permeabilization by preferential formation of Bak channels Apoptosis 15 2010 782 794
103. C.W. Shiau, J.W. Huang, D.S. Wang, J.R. Weng, C.C. Yang, C.H. Lin, C. Li, and C.S. Chen α-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function J. Biol. Chem. 281 2006 11819 11825 (Pubitemid 43855442)
104. M. Tomasetti, M.R. Rippo, R. Alleva, S. Moretti, L. Andera, J. Neuzil, and A. Procopio α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells Br. J. Cancer 90 2004 1644 1653 (Pubitemid 38648251)
105. K. Kanai, E. Kikuchi, S. Mikami, E. Suzuki, Y. Uchida, K. Kodaira, A. Miyajima, T. Ohigashi, J. Nakashima, and M. Oya Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo Cancer Sci. 101 2010 216 223
106. K. Anderson, K.A. Lawson, M. Simmons-Menchaca, L. Sun, B.G. Sanders, and K. Kline α-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis Exp. Biol. Med. (Maywood) 229 2004 1169 1176 (Pubitemid 39602260)
107. R. Tiwary, W. Yu, L.A. deGraffenried, B.G. Sanders, and K. Kline Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer Breast Cancer Res. 13 2011 R120
108. P. Ottino, and J.R. Duncan Effect of α-tocopherol succinate on free radical and lipid peroxidation levels in BL6 melanoma cells Free Radic. Biol. Med. 22 1997 1145 1151 (Pubitemid 27171955)
109. Y.H. Kang, E. Lee, M.K. Choi, J.L. Ku, S.H. Kim, Y.G. Park, and S.J. Lim Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate Int. J. Cancer 112 2004 385 392 (Pubitemid 39390601)
110. 2 + and ROS in α-tocopheryl succinate-induced mitochondrial permeabilization Int. J. Cancer 127 2010 1823 1832
111. G.A. dos Santos, R.S. Abreu e Lima, C.R. Pestana, A.S. Lima, P.S. Scheucher, C.H. Thome, H.L. Gimenes-Teixeira, B.A. Santana-Lemos, A.R. Lucena-Araujo, F.P. Rodrigues, R. Nasr, S.A. Uyemura, R.P. Falcao, H. de The, P.P. Pandolfi, C. Curti, and E.M. Rego (+)α-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo Leukemia 26 2012 451 460
112. L.F. Dong, E. Swettenham, J. Eliasson, X.F. Wang, M. Gold, Y. Medunic, M. Stantic, P. Low, L. Prochazka, P.K. Witting, J. Turanek, E.T. Akporiaye, S.J. Ralph, and J. Neuzil Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress Cancer Res. 67 2007 11906 11913
113. G.F. Kelso, C.M. Porteous, C.V. Coulter, G. Hughes, W.K. Porteous, E.C. Ledgerwood, R.A. Smith, and M.P. Murphy Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties J. Biol. Chem. 276 2001 4588 4596
114. M.P. Murphy, and R.A. Smith Targeting antioxidants to mitochondria by conjugation to lipophilic cations Annu. Rev. Pharmacol. Toxicol. 47 2007 629 656
115. 2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix Cell Metab. 13 2011 340 350
116. L.F. Dong, V.J. Jameson, D. Tilly, L. Prochazka, J. Rohlena, K. Valis, J. Truksa, R. Zobalova, E. Mahdavian, K. Kluckova, M. Stantic, J. Stursa, R. Freeman, P.K. Witting, E. Norberg, J. Goodwin, B.A. Salvatore, J. Novotna, J. Turanek, M. Ledvina, P. Hozak, B. Zhivotovsky, M.J. Coster, S.J. Ralph, R.A. Smith, and J. Neuzil Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy Free Radic. Biol. Med. 50 2011 1546 1555
117. J. Neuzil, I. Svensson, T. Weber, C. Weber, and U.T. Brunk α-Tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation FEBS Lett. 445 1999 295 300 (Pubitemid 29117231)
118. J. Neuzil, M. Zhao, G. Ostermann, M. Sticha, N. Gellert, C. Weber, J.W. Eaton, and U.T. Brunk α-Tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosomal instability Biochem. J. 362 2002 709 715 (Pubitemid 34242323)
119. S.P. Mathupala, Y.H. Ko, and P.L. Pedersen Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria Oncogene 25 2006 4777 4786 (Pubitemid 44187625)
120. A. Nakano, H. Miki, S. Nakamura, T. Harada, A. Oda, H. Amou, S. Fujii, K. Kagawa, K. Takeuchi, S. Ozaki, T. Matsumoto, and M. Abe Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate J. Bioenerg. Biomembr. 44 2012 31 38
121. C. Rodrigues-Ferreira, A.P. da Silva, and A. Galina Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase J. Bioenerg. Biomembr. 44 2012 39 49
122. Z. Chen, H. Zhang, W. Lu, and P. Huang Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate Biochim. Biophys. Acta 1787 2009 553 560
123. Y.H. Ko, B.L. Smith, Y. Wang, M.G. Pomper, D.A. Rini, M.S. Torbenson, J. Hullihen, and P.L. Pedersen Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP Biochem. Biophys. Res. Commun. 324 2004 269 275 (Pubitemid 39311489)
124. A.P. Pereira da Silva, T. El-Bacha, N. Kyaw, R.S. dos Santos, W.S. da-Silva, F.C. Almeida, A.T. Da Poian, and A. Galina Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate Biochem. J. 417 2009 717 726
125. P.L. Pedersen 3-Bromopyruvate (3BP) a fast acting, promising, powerful, specific, and effective "small molecule" anti-cancer agent taken from labside to bedside: introduction to a special issue J. Bioenerg. Biomembr. 44 2012 1 6
126. Y.H. Ko, H.A. Verhoeven, M.J. Lee, D.J. Corbin, T.J. Vogl, and P.L. Pedersen A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside J. Bioenerg. Biomembr. 44 2012 163 170
127. M. Gomez-Lazaro, M.F. Galindo, R.M. Melero-Fernandez de Mera, F.J. Fernandez-Gomez, C.G. Concannon, M.F. Segura, J.X. Comella, J.H. Prehn, and J. Jordan Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate Mol. Pharmacol. 71 2007 736 743 (Pubitemid 46294084)
128. L.S. Huang, G. Sun, D. Cobessi, A.C. Wang, J.T. Shen, E.Y. Tung, V.E. Anderson, and E.A. Berry 3-Nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme J. Biol. Chem. 281 2006 5965 5972 (Pubitemid 43847697)
129. P. Bonsi, D. Cuomo, G. Martella, G. Sciamanna, M. Tolu, P. Calabresi, G. Bernardi, and A. Pisani Mitochondrial toxins in basal ganglia disorders: from animal models to therapeutic strategies Curr. Neuropharmacol. 4 2006 69 75
130. G. Liot, B. Bossy, S. Lubitz, Y. Kushnareva, N. Sejbuk, and E. Bossy-Wetzel Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway Cell Death Differ. 16 2009 899 909
131. S. Takemori, and T.E. King Coenzyme Q: reversal of inhibition of succinate cytochrome c reductase by lipophilic compounds Science 144 1964 852 853
132. R.R. Ramsay, B.A. Ackrell, C.J. Coles, T.P. Singer, G.A. White, and G.D. Thorn Reaction site of carboxanilides and of thenoyltrifluoroacetone in complex II Proc. Natl. Acad. Sci. U. S. A. 78 1981 825 828 (Pubitemid 11159518)
133. V.G. Grivennikova, and A.D. Vinogradov Kinetics of ubiquinone reduction by the resolved succinate: ubiquinone reductase Biochim. Biophys. Acta 682 1982 491 495
134. A. Mehta, and C. Shaha Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity J. Biol. Chem. 279 2004 11798 11813 (Pubitemid 38401685)
135. J.G. Zhang, M.A. Tirmenstein, F.A. Nicholls-Grzemski, and M.W. Fariss Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and -independent cell death: protective role of antioxidants Arch. Biochem. Biophys. 393 2001 87 96 (Pubitemid 32808363)
136. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 Pt 3 2000 607 614 (Pubitemid 30410251)
137. S. Mudaliar, and R.R. Henry New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers Annu. Rev. Med. 52 2001 239 257 (Pubitemid 32195323)
138. M. Soller, S. Drose, U. Brandt, B. Brune, and A. von Knethen Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells Mol. Pharmacol. 71 2007 1535 1544 (Pubitemid 47010906)
139. J.C. Parker Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus Adv. Drug Deliv. Rev. 54 2002 1173 1197 (Pubitemid 35230000)
140. D.J. Graham, L. Green, J.R. Senior, and P. Nourjah Troglitazone-induced liver failure: a case study Am. J. Med. 114 2003 299 306 (Pubitemid 36398076)
141. S. Omura, H. Tomoda, K. Kimura, D.Z. Zhen, H. Kumagai, K. Igarashi, N. Imamura, Y. Takahashi, Y. Tanaka, and Y. Iwai Atpenins, new antifungal antibiotics produced by Penicillium sp. Production, isolation, physico-chemical and biological properties J. Antibiot. (Tokyo) 41 1988 1769 1773 (Pubitemid 19010344)
142. K. Oshino, H. Kumagai, H. Tomoda, and S. Omura Mechanism of action of atpenin B on Raji cells J. Antibiot. (Tokyo) 43 1990 1064 1068 (Pubitemid 20324367)
143. H. Miyadera, K. Shiomi, H. Ui, Y. Yamaguchi, R. Masuma, H. Tomoda, H. Miyoshi, A. Osanai, K. Kita, and S. Omura Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase) Proc. Natl. Acad. Sci. U. S. A. 100 2003 473 477 (Pubitemid 36126075)
144. R. Horsefield, V. Yankovskaya, G. Sexton, W. Whittingham, K. Shiomi, S. Omura, B. Byrne, G. Cecchini, and S. Iwata Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction J. Biol. Chem. 281 2006 7309 7316 (Pubitemid 43847499)
145. M. Kawada, I. Momose, T. Someno, G. Tsujiuchi, and D. Ikeda New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells J. Antibiot. (Tokyo) 62 2009 243 246
146. M. Kawada, H. Inoue, S. Ohba, T. Masuda, I. Momose, and D. Ikeda Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells Int. J. Cancer 126 2010 810 818
147. A.P. Wojtovich, and P.S. Brookes The complex II inhibitor atpenin A5 protects against cardiac ischemia-reperfusion injury via activation of mitochondrial KATP channels Basic Res. Cardiol. 104 2009 121 129
148. S. Drose, L. Bleier, and U. Brandt A common mechanism links differently acting complex II inhibitors to cardioprotection: modulation of mitochondrial reactive oxygen species production Mol. Pharmacol. 79 2011 814 822
149. S.J. Ralph, R. Moreno-Sanchez, J. Neuzil, and S. Rodriguez-Enriquez Inhibitors of succinate: quinone reductase/complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death Pharm. Res. 28 2011 2695 2730
150. T.P. Selby, K.A. Hughes, J.J. Rauh, and W.S. Hanna Synthetic atpenin analogs: potent mitochondrial inhibitors of mammalian and fungal succinate-ubiquinone oxidoreductase Bioorg. Med. Chem. Lett. 20 2010 1665 1668
151. M. Ohtawa, K. Sugiyama, T. Hiura, S. Izawa, K. Shiomi, S. Omura, and T. Nagamitsu Stereoselective total synthesis of atpenins a4 and b, harzianopyridone, and NBRI23477 B Chem. Pharm. Bull. (Tokyo) 60 2012 898 906
152. C. Sakai, E. Tomitsuka, H. Esumi, S. Harada, and K. Kita Mitochondrial fumarate reductase as a target of chemotherapy: from parasites to cancer cells Biochim. Biophys. Acta 1820 2012 643 651
153. F. Schiavi, C.C. Boedeker, B. Bausch, M. Peczkowska, C.F. Gomez, T. Strassburg, C. Pawlu, M. Buchta, M. Salzmann, M.M. Hoffmann, A. Berlis, I. Brink, M. Cybulla, M. Muresan, M.A. Walter, F. Forrer, M. Valimaki, A. Kawecki, Z. Szutkowski, J. Schipper, M.K. Walz, P. Pigny, C. Bauters, J.E. Willet-Brozick, B.E. Baysal, A. Januszewicz, C. Eng, G. Opocher, and H.P. Neumann Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene JAMA 294 2005 2057 2063 (Pubitemid 41539939)
154. M. Peczkowska, A. Cascon, A. Prejbisz, A. Kubaszek, B.J. Cwikla, M. Furmanek, Z. Erlic, C. Eng, A. Januszewicz, and H.P. Neumann Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation Nat. Clin. Pract. Endocrinol. Metab. 4 2008 111 115 (Pubitemid 351156901)
155. Y. Ni, K.M. Zbuk, T. Sadler, A. Patocs, G. Lobo, E. Edelman, P. Platzer, M.S. Orloff, K.A. Waite, and C. Eng Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes Am. J. Hum. Genet. 83 2008 261 268